From 23 June 2025, a new weight loss medication – Tirzepatide (Mounjaro®) – is being made available across England, but only for a small group of people at highest risk due to obesity.

⚠️ In the Black Country, GPs cannot yet prescribe Mounjaro for weight loss. Local NHS services are currently working hard to build a specialist community pathway to safely offer this treatment.

👥 Who may be eligible first (once services go live):

• BMI ≥ 40 (or ≥ 37.5 if from a minority ethnic background)
• Diagnosed with obstructive sleep apnoea (on or unsuitable for CPAP)
• AND 3 or more of the following:
  • Type 2 diabetes
  • High blood pressure
  • Cardiovascular disease
  • High cholesterol (dyslipidaemia)

📌 Please don’t contact your GP about Mounjaro for weight loss yet. They can’t prescribe it or refer you until the new service is launched.

💬 Support will include diet, exercise and behaviour change help – not just medication.

👉 We’ll keep you updated when the pathway opens.

✅ Note: Mounjaro is already available on prescription for people with type 2 diabetes – this new update only relates to weight loss use.

Thank you for your patience as we prepare to launch this exciting new service safely and fairly across the Black Country 💙

#NHSBlackCountry #WeightManagement #Mounjaro #Tirzepatide #NHSUpdate #ObesitySupport #HealthyLiving